Large Molecule

Managing Pharmacovigilance Challenges for Biosimilars

Ivana Lisec, MPharm

PrimeVigilance

Particle ID

Leveraging Formulation Development Experience for Effective Particle Identification

Jörg Müller, Ph.D.

Coriolis Pharma

Precision Medicine

Advancing Personalized Medicines and Precision Therapeutics

Thermo Fisher Scientific

Bioassays

State-of-the-Art, Multi-Modality Bioanalysis in Brisbane

Resolian

Clinical Trials

ProPharma Group is Supporting Better Clinical Outcomes Down Under

ProPharma

Clinical Trials

Passion and Understanding Essential for Rare Disease Clinical Trials

Juliet Moritz

Ergomed

Oncology Trials

Navigating the Complex Landscape of Oncology Trials

Colin Hayward, MB BS

Ergomed

Commercialization

Development Strategies for Overcoming Commercialization Challenges

Matthias Lucke, Ph.D.

Coriolis Pharma

Ophthalmology

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.

PPD, part of Thermo Fisher Scientific

IND Enablement

IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"

Johannes Clemens

Coriolis Pharma

Changing Roles

How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?

Pharma's Almanac

Global Access

How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?

Pharma's Almanac

Developability

Streamlining the Path to Approval with Developability and Pre-Formulation Platforms

Andrea Hawe

Coriolis Pharma

CDMO Model

Rethinking the Conventional CDMO Model

Wheeler Bio

CRDO

Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development

Silvia Steyrer-Gruber

Coriolis Pharma

Cell and Gene Therapy

Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies

Erin Schaller; Aidan Jones

PPD, part of Thermo Fisher Scientific

Pharmacovigilance

Navigating Shifting Requirements and an Explosion of Data in Pharmacovigilance

Sally Amanuel

PrimeVigilance

Pediatric Clinical Trials

Pediatric Clinical Trials: Considerations for Enrollment and Retention

Susan McCune, M.D.; Anusha Streubel, M.D.; Elizabeth Donahue